Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Net Income: 2016-2024

Historic Net Income for Dianthus Therapeutics (DNTH) over the last 7 years, with Dec 2024 value amounting to -$84.5 million.

  • Dianthus Therapeutics' Net Income fell 43.90% to -$36.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$125.5 million, marking a year-over-year decrease of 87.03%. This contributed to the annual value of -$84.5 million for FY2024, which is 94.65% down from last year.
  • Dianthus Therapeutics' Net Income amounted to -$84.5 million in FY2024, which was down 94.65% from -$43.4 million recorded in FY2023.
  • In the past 5 years, Dianthus Therapeutics' Net Income registered a high of -$28.6 million during FY2022, and its lowest value of -$84.5 million during FY2024.
  • In the last 3 years, Dianthus Therapeutics' Net Income had a median value of -$43.4 million in 2023 and averaged -$52.2 million.
  • Data for Dianthus Therapeutics' Net Income shows a maximum YoY slumped of 94.65% (in 2024) over the last 5 years.
  • Over the past 3 years, Dianthus Therapeutics' Net Income (Yearly) stood at -$28.6 million in 2022, then slumped by 52.00% to -$43.4 million in 2023, then crashed by 94.65% to -$84.5 million in 2024.